Aptevo Therapeutics achieves major breakthrough with mipletamig in acute myeloid leukemia

Pallavi Madhiraju- December 12, 2024 0

Aptevo Therapeutics has unveiled remarkable findings from Cohort 1 of its RAINIER clinical trial for mipletamig, a bispecific antibody aimed at tackling acute myeloid leukemia ... Read More

OncoVerity accelerates AML treatment with Series A extension

Pallavi Madhiraju- November 23, 2024 0

OncoVerity, a leader in integrating bioinformatics with oncology drug development, has closed a Series A extension financing round, bolstered by its key investors, argenx and ... Read More